• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Possibility of anti-Semaphorin 4D antibody for the neuro regenerative therapy in experimental cerabral infarction

Research Project

Project/Area Number 25860730
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Neurology
Research InstitutionHyogo Medical University

Principal Investigator

TAKATA MASASHI  兵庫医科大学, 医学部, 助教 (60617984)

Project Period (FY) 2013-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords抗Sema4D抗体 / 神経幹細胞 / 脳梗塞 / 内因性神経再生
Outline of Final Research Achievements

The inflammation induced by cerebral ischemia exacerbates neuronal damage, and enhances neuro reparative mechanisms. In this study , by using a highly reproducible murine model of experimental stroke, we examined the effect of endogeneous neurogenesis and neuronal damage after cerebral infarction by suppressing Semaphorin4D on the lymphocyte using anti-Semaphprin4D antibody. Administration of anti-Semaphorin4D antibody into poststroke mice reduced the size of infarcted area,increased the number of neural stem cells and the expression of neural stem cell marker, and improved their behavior. Our findings demonstrated anti-Semaphorin4D antibody may be useful as a novel endogenous regenerative therapy in stroke treatment.

Report

(3 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi